The brain response to peripheral insulin declines with age: A contribution of the blood-brain barrier?

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Sartorius, Tina ^a,b   Peter, Andreas ^a,b   Heni, Martin ^a,b   Maetzler, Walter ^c,d   Fritsche, Andreas ^a,b   Häring, Hans Ulrich ^a,b   Hennige, Anita M ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

^c UNIVERSITY OF TÜBINGEN   (Germany)

^d GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; GLUCOSE; INSULIN; PROTEIN KINASE B; ALBUMINOID; GLUCOSE BLOOD LEVEL; SERUM ALBUMIN;

ADULT; AGED; AGING; ALBUMIN BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; BODY WEIGHT; CEREBROSPINAL FLUID LEVEL; ELECTROCORTICOGRAPHY; EXPLORATORY RESEARCH; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; JUVENILE ANIMAL; MALE; MOUSE; NONHUMAN; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING; ANIMAL; BLOOD; BRAIN; CENTRAL NERVOUS SYSTEM; CEREBROSPINAL FLUID; GENETICS; INSULIN RESISTANCE; METABOLISM; PATHOLOGY;

ANIMALIA; MURINAE; MUS;

AGED; AGING; ALBUMINS; ANIMALS; BLOOD GLUCOSE; BLOOD-BRAIN BARRIER; BRAIN; CENTRAL NERVOUS SYSTEM; GLUCOSE; HUMANS; INSULIN; INSULIN RESISTANCE; MICE; SERUM ALBUMIN;

EID: 84930660574     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0126804     Document Type: Article

References (57)

1. Alves MG, Oliveira PF, Socorro S, Moreira PI. Impact of diabetes in blood-testis and blood-brain barriers: resemblances and differences. Curr Diabetes Rev. 2012; 8: 401-412. PMID: 22934551
2. De Felice FG. Alzheimer's disease and insulin resistance: translating basic science into clinical applications. J Clin Invest. 2013; 123: 531-539. doi: 10.1172/JCI64595 PMID: 23485579
3. Ott V, Benedict C, Schultes B, Born J, Hallschmid M. Intranasal administration of insulin to the brain impacts cognitive function and peripheral metabolism. Diabetes Obes Metab. 2012; 14: 214-221. doi: 10.1111/j.1463-1326.2011.01490.x PMID: 21883804
4. Hennige AM, Sartorius T, Lutz SZ, Tschritter O, Preissl H, Hopp S, et al. Insulin-mediated cortical activity in the slow frequency range is diminished in obese mice and promotes physical inactivity. Diabetologia. 2009; 52: 2416-2424. doi: 10.1007/s00125-009-1522-5 PMID: 19756482
5. Guthoff M, Stingl KT, Tschritter O, Rogic M, Heni M, Stingl K, et al. The insulin-mediated modulation of visually evoked magnetic fields is reduced in obese subjects. PLoS One. 2011; 6: e19482. doi: 10.1371/journal.pone.0019482 PMID: 21589921
6. Sartorius T, Lutz SZ, Hoene M, Waak J, Peter A, Weigert C, et al. Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture. FASEB J. 2012; 26: 1799-1809. doi: 10.1096/fj.11-191023 PMID: 22278939
7. Tschritter O, Preissl H, Hennige AM, Sartorius T, Grichisch Y, Stefan N, et al. The insulin effect on cerebrocortical theta activity is associated with serum concentrations of saturated nonesterified Fatty acids. J Clin Endocrinol Metab. 2009; 94: 4600-4607. doi: 10.1210/jc.2009-0469 PMID: 19820026
8. Sartorius T, Ketterer C, Kullmann S, Balzer M, Rotermund C, Binder S, et al. Monounsaturated fatty acids prevent the aversive effects of obesity on locomotion, brain activity, and sleep behavior. Diabetes. 2012; 61: 1669-1679. doi: 10.2337/db11-1521 PMID: 22492529
9. Tschritter O, Preissl H, Hennige AM, Stumvoll M, Porubska K, Frost R, et al. The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study. Proc Natl Acad Sci U S A. 2006; 103: 12103-12108. PMID: 16877540
10. Tschritter O, Haupt A, Preissl H, Ketterer C, Hennige AM, Sartorius T, et al. An Obesity Risk SNP (rs17782313) near the MC4R Gene Is Associated with Cerebrocortical Insulin Resistance in Humans. J Obes. 2011; 2011: 283153. doi: 10.1155/2011/283153 PMID: 21773004
11. Ketterer C, Heni M, Stingl K, Tschritter O, Linder K, Wagner R, et al. Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action. Obesity (Silver Spring). 2014; 22: 925-931. doi: 10.1002/oby.20573 PMID: 23839870
12. Tschritter O, Preissl H, Yokoyama Y, Machicao F, Haring HU, Fritsche A. Variation in the FTO gene locus is associated with cerebrocortical insulin resistance in humans. Diabetologia. 2007; 50: 2602-2603. PMID: 17917711
13. Tschritter O, Hennige AM, Preissl H, Grichisch Y, Kirchhoff K, Kantartzis K, et al. Insulin effects on beta and theta activity in the human brain are differentially affected by ageing. Diabetologia. 2009; 52: 169-171. doi: 10.1007/s00125-008-1187-5 PMID: 19018512
14. Li L, Holscher C. Common pathological processes in Alzheimer disease and type 2 diabetes: a review. Brain Res Rev. 2007; 56: 384-402. PMID: 17920690
15. Chechlacz M, Rotshtein P, Klamer S, Porubska K, Higgs S, Booth D, et al. Diabetes dietary management alters responses to food pictures in brain regions associated with motivation and emotion: a functional magnetic resonance imaging study. Diabetologia. 2009; 52: 524-533. doi: 10.1007/s00125-008-1253-z PMID: 19139843
16. Rotte M, Baerecke C, Pottag G, Klose S, Kanneberg E, Heinze HJ, et al. Insulin affects the neuronal response in the medial temporal lobe in humans. Neuroendocrinology. 2005; 81: 49-55. PMID: 15809512
17. Guthoff M, Grichisch Y, Canova C, Tschritter O, Veit R, Hallschmid M, et al. Insulin modulates food-related activity in the central nervous system. J Clin Endocrinol Metab. 2010; 95: 748-755. doi: 10.1210/jc.2009-1677 PMID: 19996309
18. Cholerton B, Baker LD, Craft S. Insulin resistance and pathological brain ageing. Diabet Med. 2011; 28: 1463-1475. doi: 10.1111/j.1464-5491.2011.03464.x PMID: 21974744
19. Banks WA, Jaspan JB, Huang W, Kastin AJ. Transport of insulin across the blood-brain barrier: saturability at euglycemic doses of insulin. Peptides. 1997; 18: 1423-1429. PMID: 9392846
20. Urayama A, Banks WA. Starvation and triglycerides reverse the obesity-induced impairment of insulin transport at the blood-brain barrier. Endocrinology. 2008; 149: 3592-3597. doi: 10.1210/en.2008-0008 PMID: 18403490
21. Shah GN, Mooradian AD. Age-related changes in the blood-brain barrier. Exp Gerontol. 1997; 32: 501-519. PMID: 9315452
22. Zeevi N, Pachter J, McCullough LD, Wolfson L, Kuchel GA. The blood-brain barrier: geriatric relevance of a critical brain-body interface. J Am Geriatr Soc. 2010; 58: 1749-1757. doi: 10.1111/j.1532-5415.2010.03011.x PMID: 20863334
23. Persidsky Y, Ramirez SH, Haorah J, Kanmogne GD. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J Neuroimmune Pharmacol. 2006; 1: 223-236. PMID: 18040800
24. Wardlaw JM, Sandercock PA, Dennis MS, Starr J. Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia? Stroke. 2003; 34: 806-812. PMID: 12627547
25. Woods SC, Seeley RJ, Baskin DG, Schwartz MW. Insulin and the blood-brain barrier. Curr Pharm Des. 2003; 9: 795-800. PMID: 12678878
26. Schwartz MW, Figlewicz DF, Kahn SE, Baskin DG, Greenwood MR, Porte D Jr. Insulin binding to brain capillaries is reduced in genetically obese, hyperinsulinemic Zucker rats. Peptides. 1990; 11: 467-472. PMID: 2199946
27. King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science. 1985; 227: 1583-1586. PMID: 3883490
28. Duffy KR, Pardridge WM. Blood-brain barrier transcytosis of insulin in developing rabbits. Brain Research. 1987; 420: 32-38. PMID: 3315116
29. Banks WA, Kastin AJ. Peptides and the blood-brain barrier: lipophilicity as a predictor of permeability. Brain Res Bull. 1985; 15: 287-292. PMID: 2413968
30. Hachiya HL, Halban PA, King GL. Intracellular pathways of insulin transport across vascular endothelial cells. Am J Physiol. 1988; 255: C459-C464. PMID: 3052101
31. Heni M, Schöpfer P, Peter A, Sartorius T, Fritsche A, Synofzik M, et al. Evidence for altered transport of insulin across the blood-brain barrier in insulin-resistant humans. Acta Diabetol. 2014; 51(4): 679-81. doi: 10.1007/s00592-013-0546-y PMID: 24370925
32. Bayer-Carter JL, Green PS, Montine TJ, VanFossen B, Baker LD, Watson GS, et al. Diet intervention and cerebrospinal fluid biomarkers in amnestic mild cognitive impairment. Arch Neurol. 2011; 68: 743-752. doi: 10.1001/archneurol.2011.125 PMID: 21670398
33. Benedict C, Brooks SJ, Kullberg J, Burgos J, Kempton MJ, Nordenskjöld R, et al. Impaired insulin sensitivity as indexed by the HOMA score is associated with deficits in verbal fluency and temporal lobe gray matter volume in the elderly. Diabetes Care. 2012; 35: 488-494. doi: 10.2337/dc11-2075 PMID: 22301128
34. Cole GM, Frautschy SA. The role of insulin and neurotrophic factor signaling in brain aging and Alzheimer's Disease. Exp Gerontol. 2007; 42: 10-21. PMID: 17049785
35. Craft S. The role of metabolic disorders in Alzheimer disease and vascular dementia: two roads converged. Arch Neurol. 2009; 66: 300-305. doi: 10.1001/archneurol.2009.27 PMID: 19273747
36. Ribeiro RT, Afonso RA, Guarino MP, Macedo MP. Loss of postprandial insulin sensitization during aging. J Gerontol A Biol Sci Med Sci. 2008; 63: 560-565. PMID: 18559629
37. Park CR, Seeley RJ, Craft S, Woods SC. Intracerebroventricular insulin enhances memory in a passive-avoidance task. Physiol Behav. 2000; 68: 509-514. PMID: 10713291
38. Alquier T, Leloup C, Atef N, Fioramonti X, Lorsignol A, Pénicaud L. Cerebral insulin increases brain response to glucose. J Neuroendocrinol. 2003; 15: 75-79. PMID: 12535172
39. Fujita N, Sakamaki H, Uotani S, Takahashi R, Kuwahara H, Kita A, et al. Intracerebroventricular administration of insulin and glucose inhibits the anorectic action of leptin in rats. Exp Biol Med (Maywood). 2003; 228: 1156-1161. PMID: 14610254
40. Nerad L, Bilkey DK. Ten- to 12-Hz EEG oscillation in the rat hippocampus and rhinal cortex that is modulated by environmental familiarity. J Neurophysiol. 2005; 93: 1246-1254. PMID: 15738273
41. Reiber H. Proteins in cerebrospinal fluid and blood: barriers, CSF flow rate and source-related dynamics. Restor Neurol Neurosci. 2003; 21: 79-96. PMID: 14530572
42. Baura GD, Foster DM, Porte D Jr., Kahn SE, Bergman RN, Cobelli C, et al. Saturable transport of insulin from plasma into the central nervous system of dogs in vivo. A mechanism for regulated insulin delivery to the brain. J Clin Invest. 1993; 92: 1824-1830. PMID: 8408635
43. Nolan JJ. Ageing brain abnormalities in young obese patients with type 2 diabetes: a cause for concern. Diabetologia. 2010; 53: 2273-2275. doi: 10.1007/s00125-010-1890-x PMID: 20803339
44. Craft S, Peskind E, Schwartz MW, Schellenberg GD, Raskind M, Porte D Jr. Cerebrospinal fluid and plasma insulin levels in Alzheimer's disease: relationship to severity of dementia and apolipoprotein E genotype. Neurology. 1998; 50: 164-168. PMID: 9443474
45. Ketterer C, Tschritter O, Preissl H, Heni M, Haring HU, Fritsche A. Insulin sensitivity of the human brain. Diabetes Res Clin Pract. 2011; 93 Suppl 1: S47-S51. doi: 10.1016/S0168-8227(11)70013-4 PMID: 21864751
46. Seaquist ER, Chen W, Benedict LE, Ugurbil K, Kwag JH, Zhu XH, et al. Insulin reduces the BOLD response but is without effect on the VEP during presentation of a visual task in humans. J Cereb Blood Flow Metab. 2007; 27: 154-160. PMID: 16639425
47. Heni M, Wagner R, Kullmann S, Veit R, Mat-Husin H, Linder K, et al. Central insulin administration improves whole-body insulin sensitivity via hypothalamus and parasympathetic outputs in men. Diabetes. 2014; 63(12): 4083-8. doi: 10.2337/db14-0477 PMID: 25028522
48. Tschritter O, Preissl H, Hennige AM, Sartorius T, Stingl KT, Heni M, et al. High cerebral insulin sensitivity is associated with loss of body fat during lifestyle intervention. Diabetologia. 2012; 55: 175-182. doi: 10.1007/s00125-011-2309-z PMID: 21927893
49. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Schwartz MW. Obesity induced by a high-fat diet is associated with reduced brain insulin transport in dogs. Diabetes. 2000; 49: 1525-1533. PMID: 10969837
50. Houtkooper RH, Argmann C, Houten SM, Canto C, Jeninga EH, Andreux PA, et al. The metabolic footprint of aging in mice. Sci Rep. 2011; 1: 134. doi: 10.1038/srep00134 PMID: 22355651
51. Richard Clark C, Veltmeyer MD, Hamilton RJ, Simms E, Paul R, Hermens D, et al. Spontaneous alpha peak frequency predicts working memory performance across the age span. Int J Psychophysiol. 2004; 53: 1-9. PMID: 15172130
52. Leirer VM, Wienbruch C, Kolassa S, Schlee W, Elbert T, Kolassa IT. Changes in cortical slow wave activity in healthy aging. Brain Imaging Behav. 2011; 5: 222-228. doi: 10.1007/s11682-011-9126-3 PMID: 21698438
53. Tucsek Z, Toth P, Tarantini S, Sosnowska D, Gautam T, Warrington JP, et al. Aging exacerbates obesity-induced cerebromicrovascular rarefaction, neurovascular uncoupling, and cognitive decline in mice. J Gerontol A Biol Sci Med Sci. 2014; 69: 1339-1352. doi: 10.1093/gerona/glu080 PMID: 24895269
54. Kloet DE, Burgering BM. The PKB/FOXO switch in aging and cancer. Biochim Biophys Acta. 2011; 1813: 1926-1937. doi: 10.1016/j.bbamcr.2011.04.003 PMID: 21539865
55. Cohen BM, Renshaw PF, Stoll AL, Wurtman RJ, Yurgelun-Todd D, Babb SM. Decreased brain choline uptake in older adults. An in vivo proton magnetic resonance spectroscopy study. JAMA. 1995; 274: 902-907. PMID: 7674505
56. Allen DD, Smith QR. Blood-brain barrier choline transport in the senescent rat. Neurosci Lett. 1999; 277: 198-202. PMID: 10626847
57. Banks WA, Coon AB, Robinson SM, Moinuddin A, Shultz JM, Nakaoke R, et al. Triglycerides induce leptin resistance at the blood-brain barrier. Diabetes. 2004; 53: 1253-1260. PMID: 15111494